Serostim $704 Mil. Settlement Is Largest For Off-Label Marketing Case

Serono's $704 mil. settlement over Serostim promotional practices marks the largest penalty ever paid by a pharmaceutical manufacturer to resolve civil and criminal investigations into off-label marketing